Altered plasma levels of cytokines, soluble adhesion molecules and matrix metalloproteases in venous thrombosis

Thrombosis Research

Volumn 136, Issue 1, 2015, Pages 30-39

  Mosevoll, Knut Anders ^a,b   Lindås, Roald ^b   Tvedt, Tor Henrik Anderson ^b   Bruserud, Oystein ^a,b   Reikvam, Håkon ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Cell adhesion molecules; Chemokines; Cytokines; Interleukins; Metalloproteases venous thrombosis

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; BIOLOGICAL MARKER; CD40 LIGAND; CELL ADHESION MOLECULE; CYTOKINE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 22; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; NEUTROPHIL COLLAGENASE; PADGEM PROTEIN; SCATTER FACTOR; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN; AUTACOID; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D; INTERCELLULAR ADHESION MOLECULE 1; SIGNAL PEPTIDE;

ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; HOSPITAL ADMISSION; HUMAN; INFECTION; INFLAMMATION; LOWER EXTREMITY DEEP VEIN THROMBOSIS; LUNG EMBOLISM; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; THROMBOPHLEBITIS; BLOOD; COHORT ANALYSIS; VEIN THROMBOSIS;

BIOMARKERS; CELL ADHESION MOLECULES; COHORT STUDIES; CYTOKINES; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; INFLAMMATION MEDIATORS; INTERCELLULAR ADHESION MOLECULE-1; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MATRIX METALLOPROTEINASES; P-SELECTIN; VASCULAR CELL ADHESION MOLECULE-1; VENOUS THROMBOSIS;

EID: 84931568807     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2015.04.002     Document Type: Article

References (38)

1. M. Tan, C.J. van Rooden, R.E. Westerbeek, and M.V. Huisman Diagnostic management of clinically suspected acute deep vein thrombosis Br J Haematol 146 2009 347 360
2. B.G. Birdwell, G.E. Raskob, T.L. Whitsett, S.S. Durica, P.C. Comp, and J.N. George The clinical validity of normal compression ultrasonography in outpatients suspected of having deep venous thrombosis Ann Intern Med 128 1998 1 7
3. C. Kearon, J.A. Julian, T.E. Newman, and J.S. Ginsberg Noninvasive diagnosis of deep venous thrombosis. McMaster Diagnostic Imaging Practice Guidelines Initiative Ann Intern Med 128 1998 663 677
4. I. Hrachovinova, B. Cambien, A. Hafezi-Moghadam, J. Kappelmayer, R.T. Camphausen, and A. Widom Interaction of P-selectin and PSGL-1 generates microparticles that correct hemostasis in a mouse model of hemophilia A Nat Med 9 2003 1020 1025
5. E. Ramacciotti, S. Blackburn, A.E. Hawley, F. Vandy, N. Ballard-Lipka, and C. Stabler Evaluation of soluble P-selectin as a marker for the diagnosis of deep venous thrombosis Clin Appl Thromb Hemost 17 2011 425 431
6. J.E. Rectenwald, D.D. Myers Jr., A.E. Hawley, C. Longo, P.K. Henke, and K.E. Guire D-dimer, P-selectin, and microparticles: novel markers to predict deep venous thrombosis. A pilot study Thromb Haemost 94 2005 1312 1317
7. S. Ota, N. Yamada, Y. Ogihara, A. Tsuji, K. Ishikura, and M. Nakamura High plasma level of factor VIII: an important risk factor for venous thromboembolism Circ J 75 2011 1472 1475
8. V. Tichelaar, A. Mulder, H. Kluin-Nelemans, and K. Meijer The acute phase reaction explains only a part of initially elevated factor VIII:C levels: a prospective cohort study in patients with venous thrombosis Thromb Res 129 2012 183 186
9. R.A. Kraaijenhagen, P.S. in't Anker, M.M. Koopman, P.H. Reitsma, M.H. Prins, and A. van den Ende High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism Thromb Haemost 83 2000 5 9
10. K.E. Brummel-Ziedins, C.Y. Vossen, S. Butenas, K.G. Mann, and F.R. Rosendaal Thrombin generation profiles in deep venous thrombosis J Thromb Haemost 3 2005 2497 2505
11. B.E. van Aken, M. den Heijer, G.M. Bos, S.J. van Deventer, and P.H. Reitsma Recurrent venous thrombosis and markers of inflammation Thromb Haemost 83 2000 536 539
12. B.E. van Aken, P.H. Reitsma, and F.R. Rosendaal Interleukin 8 and venous thrombosis: evidence for a role of inflammation in thrombosis Br J Haematol 116 2002 173 177
13. P.H. Reitsma, and F.R. Rosendaal Activation of innate immunity in patients with venous thrombosis: the Leiden Thrombophilia Study J Thromb Haemost 2 2004 619 622
14. A. Ghosh, W. Li, M. Febbraio, R.G. Espinola, K.R. McCrae, and E. Cockrell Platelet CD36 mediates interactions with endothelial cell-derived microparticles and contributes to thrombosis in mice J Clin Invest 118 2008 1934 1943
15. M.L. von Bruhl, K. Stark, A. Steinhart, S. Chandraratne, I. Konrad, and M. Lorenz Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo J Exp Med 209 2012 819 835
16. M.F. Matos, D.M. Lourenco, C.M. Orikaza, J.A. Bajerl, M.A. Noguti, and V.M. Morelli The role of IL-6, IL-8 and MCP-1 and their promoter polymorphisms IL-6 -174GC, IL-8 -251AT and MCP-1 -2518AG in the risk of venous thromboembolism: a case-control study Thromb Res 128 2011 216 220
17. P. Poredos, and M.K. Jezovnik In patients with idiopathic venous thrombosis, interleukin-10 is decreased and related to endothelial dysfunction Heart Vessels 26 2011 596 602
18. P.W. Kamphuisen, J.C. Eikenboom, H.L. Vos, R. Pablo, A. Sturk, and R.M. Bertina Increased levels of factor VIII and fibrinogen in patients with venous thrombosis are not caused by acute phase reactions Thromb Haemost 81 1999 680 683
19. S.C. Christiansen, I.A. Naess, S.C. Cannegieter, J. Hammerstrom, F.R. Rosendaal, and P.H. Reitsma Inflammatory cytokines as risk factors for a first venous thrombosis: a prospective population-based study PLoS Med 3 2006 e334
20. H. Reikvam, K.A. Mosevoll, G.K. Melve, C.C. Gunther, M. Sjo, and P.T. Bentsen The pretransplantation serum cytokine profile in allogeneic stem cell recipients differs from healthy individuals, and various profiles are associated with different risks of posttransplantation complications Biol Blood Marrow Transplant 18 2012 190 199
21. A.K. Stavrum, K. Petersen, I. Jonassen, and B. Dysvik Analysis of gene-expression data using J-Express Curr Protoc Bioinformatics 21 2008 7.3.1 7.3.25
22. R. Hull, J. Hirsh, D.L. Sackett, D.W. Taylor, C. Carter, and A.G. Turpie Clinical validity of a negative venogram in patients with clinically suspected venous thrombosis Circulation 64 1981 622 625
23. W.P. Gorman, K.R. Davis, and R. Donnelly ABC of arterial and venous disease. Swollen lower limb-1: general assessment and deep vein thrombosis BMJ 320 2000 1453 1456
24. P.S. Wells, J. Hirsh, D.R. Anderson, A.W. Lensing, G. Foster, and C. Kearon Accuracy of clinical assessment of deep-vein thrombosis Lancet 345 1995 1326 1330
25. C.N. Antonopoulos, G.S. Sfyroeras, J.D. Kakisis, K.G. Moulakakis, and C.D. Liapis The role of soluble P selectin in the diagnosis of venous thromboembolism Thromb Res 133 2013 17 24
26. M. Bozic, A. Blinc, and M. Stegnar D-dimer, other markers of haemostasis activation and soluble adhesion molecules in patients with different clinical probabilities of deep vein thrombosis Thromb Res 108 2002 107 114
27. A.J. Gonzalez-Ordonez, J.M. Fernandez-Carreira, C.R. Fernandez-Alvarez, R. Venta Obaya, M.D. Macias-Robles, and A. Gonzalez-Franco The concentrations of soluble vascular cell adhesion molecule-1 and lipids are independently associated with venous thromboembolism Haematologica 88 2003 1035 1043
28. R.A. Bucek, M. Reiter, P. Quehenberger, E. Minar, and M. Baghestanian The role of soluble cell adhesion molecules in patients with suspected deep vein thrombosis Blood Coagul Fibrinolysis 14 2003 653 657
29. G.C. Connolly, and A.A. Khorana Emerging risk stratification approaches to cancer-associated thrombosis: risk factors, biomarkers and a risk score Thromb Res 125 Suppl. 2 2010 S1 S7
30. F.C. Vandy, C. Stabler, A.M. Eliassen, A.E. Hawley, K.E. Guire, and D.D. Myers Soluble P-selectin for the diagnosis of lower extremity deep venous thrombosis J Vasc Surg Venous Lymphat Disord 1 2013 117 1125
31. L. Borsig Antimetastatic activities of modified heparins: selectin inhibition by heparin attenuates metastasis Semin Thromb Hemost 33 2007 540 546
32. J.C. Tardif, J.F. Tanguay, S.S. Wright, V. Duchatelle, T. Petroni, and J.C. Gregoire Effects of the P-selectin antagonist inclacumab on myocardial damage after percutaneous coronary intervention for non-ST elevation myocardial infarction Results of the SELECT-ACS Trial J Am Coll Cardiol 61 2013 2048 2055
33. T.R. Meier, D.D. Myers Jr., S.K. Wrobleski, P.J. Zajkowski, A.E. Hawley, and P.W. Bedard Prophylactic P-selectin inhibition with PSI-421 promotes resolution of venous thrombosis without anticoagulation Thromb Haemost 99 2008 343 351
34. M. Nosaka, Y. Ishida, A. Kimura, Y. Kuninaka, M. Inui, and N. Mukaida Absence of IFN-gamma accelerates thrombus resolution through enhanced MMP-9 and VEGF expression in mice J Clin Invest 121 2011 2911 2920
35. K.B. Deatrick, M. Elfline, N. Baker, C.E. Luke, S. Blackburn, and C. Stabler Postthrombotic vein wall remodeling: preliminary observations J Vasc Surg 53 2011 139 146
36. M.T. Busceti, R. Grande, B. Amato, V. Gasbarro, G. Buffone, and M. Amato Pulmonary embolism, metalloproteinases and neutrophil gelatinase associated lipocalin Acta Phlebol 14 2013 115 121
37. M.K. Jezovnik, and P. Poredos Idiopathic venous thrombosis is related to systemic inflammatory response and to increased levels of circulating markers of endothelial dysfunction Int Angiol 29 2010 226 231
38. E.M. Roumen-Klappe, M. den Heijer, S.H. van Uum, J. van der Ven-Jongekrijg, F. van der Graaf, and H. Wollersheim Inflammatory response in the acute phase of deep vein thrombosis J Vasc Surg 35 2002 701 706